Cargando…

Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review

Over time, the SARS-CoV-2 virus has acquired several genetic mutations, particularly on the receptor-binding domain (RBD) spike glycoprotein. The Omicron variant is highly infectious, with enhanced immune escape activity, and has given rise to various sub-lineages due to mutations. However, there ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chenchula, Santenna, Amerneni, Krishna Chaitanya, Ghanta, Mohan Krishna, Padmavathi, R., Chandra, Madhu Bhargavi, Adusumilli, Madhu Babu, Chavan, Madhavrao, Mudda, Sofia, Gupta, Rupesh, Lakhawat, Bhawna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197433/ https://www.ncbi.nlm.nih.gov/pubmed/37229914 http://dx.doi.org/10.1016/j.virol.2023.04.007

Ejemplares similares

Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression
por: Chenchula, Santenna, et al.
Publicado: (2023)

The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis
por: Santenna, Chenchula, et al.
Publicado: (2021)

BF.7 Omicron subvariant (BA.5.2.1.7) posing fears of a rise in COVID-19 cases again: a critical appraisal and salient counteracting strategies
por: Dhama, Kuldeep, et al.
Publicado: (2023)

Epidemiology, clinical presentation and treatment outcomes in patients with COVID-19 in an ambulatory setting: a cross sectional study during the massive SARS-CoV-2 wave in India
por: Sharma, Sushil, et al.
Publicado: (2023)

Assessment of WHO core drug use indicators at a tertiary care Institute of National importance in India
por: Chenchula, Santenna, et al.
Publicado: (2022)

Anti-arthritic efficacy of Bombax ceiba ethanolic extract in a murine model for rheumatoid arthritis using in vivo, in vitro and radiological analysis
por: Posinasetty, Bhargavi, et al.
Publicado: (2023)

Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in China
por: Sun, Yamin, et al.
Publicado: (2023)

Is BF.7 more infectious than other Omicron subtypes: Insights from structural and simulation studies of BF.7 spike RBD variant
por: Singh, Jaikee Kumar, et al.
Publicado: (2023)

Anti-inflammatory and arthritic activity of zaltoprofen compared to piroxicam in murine models
por: Sadasivam, Balakrishnan, et al.
Publicado: (2022)

Clinical characteristics of abruptly increased paediatric patients with Omicron BF.7 or BA.5.2 in Beijing
por: Yu, Lei, et al.
Publicado: (2023)

Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol
por: Kelleni, Mina T.
Publicado: (2023)

BF.7 Omicron subvariant in India and China: a raising concern – correspondence
por: Sah, Ranjit, et al.
Publicado: (2023)

Genomic Recombination of SARS-CoV-2 Subvariants BA.5.2.48 and BF.7.14 — China, 2023
por: Zhang, Zhongxian, et al.
Publicado: (2023)

Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells
por: Mishra, Dipti Ranjan, et al.
Publicado: (2015)

Effectiveness of first and second boost COVID-19 vaccination in healthy adults during BA.5.2/BF.7 surge in China
por: Zhang, Yongchang, et al.
Publicado: (2023)

The First Case of Co-Infection with Omicron Subvariants BA.5.2.48 and BF.7.14 — Chongqing Municipality, China, February 2023
por: Su, Kun, et al.
Publicado: (2023)

No Novel Prevalent Mutations Detected in the Circulating Strains of BF.7, BA.5.2, DY, and XBB — China, November 2022 to June 2023
por: Wang, Liang, et al.
Publicado: (2023)

The SARS-CoV-2 Hydra, a tiny monster from the 21st century: Thermodynamics of the BA.5.2 and BF.7 variants
por: Popovic, Marko
Publicado: (2023)

Foldscope: Diagnostic Accuracy and Feasibility of its Use in National Malaria Control Program
por: Gupta, Sweta, et al.
Publicado: (2021)

Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
por: Qu, Panke, et al.
Publicado: (2023)

Erratum to: Milk Containing BF-7 Enhances the Learning and Memory, Attention, and Mathematical Ability of Normal Persons
por: Kim, Do-Hee, et al.
Publicado: (2020)

Possible threat of the Omicron subvariants XBB.1.5 and BF.7 to the Indian subcontinent: A correspondence
por: Ghosh, Shankhaneel, et al.
Publicado: (2023)

Atypical traumatic retinal tear
por: Adusumilli, Himabindu, et al.
Publicado: (2020)

Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
por: Qu, Panke, et al.
Publicado: (2022)

Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2023)

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
por: Zuo, Fanglei, et al.
Publicado: (2023)

Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination(1)
por: Wang, Hongyu, et al.
Publicado: (2023)

B.F. Skinner : in memoriam /
Publicado: (1994)

Delineating the Structure–Dynamics–Binding Differences among BA.1, BA.4/5, and BF.7 SARS-CoV-2 Variants through Atomistic Simulations: Correlation with Structural and Epidemiological Features
por: Joshi, Aryaman, et al.
Publicado: (2023)

Curcuminoid–BF(2) complexes: Synthesis, fluorescence and optimization of BF(2) group cleavage
por: Weiss, Henning, et al.
Publicado: (2017)

B.F. Skinner : consensus and controversy /
Publicado: (1987)

The Skyrme model predictions for the ${\bf 27}_{J=3/2}$ mass spectrum and the ${\bf 27}_{3/2}$-$\bar{\bf 10}$ mass splittings
por: Duplancic, G., et al.
Publicado: (2004)

Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2
por: Zhu, Airu, et al.
Publicado: (2023)

A Comparison of Clinical Characteristics of Infections with SARS-CoV-2 Omicron Subvariants BF.7.14 and BA.5.2.48 — China, October–December 2022
por: Huo, Da, et al.
Publicado: (2023)

Low-temperature modification of Ba(BF(4))(2)(H(2)O)(3)
por: Goreshnik, Evgeny, et al.
Publicado: (2023)

Phylodynamics of HIV-1 Circulating Recombinant Forms 12_BF and 38_BF in Argentina and Uruguay
por: Bello, Gonzalo, et al.
Publicado: (2010)

In Situ Anodically Oxidized BMIm-BF(4): A Safe and Recyclable BF(3) Source
por: Bortolami, Martina, et al.
Publicado: (2021)

Moments of inertia, nucleon axial-vector coupling, the {\bf 8}, {\bf 10}, $\bar{\bf 10}$ and ${\bf 27}_{3/2}$ mass spectrums and the higher SU(3)_f representation mass splittings in the Skyrme model
por: Duplancic, G., et al.
Publicado: (2004)

COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
por: Chen, Wei-Chun, et al.
Publicado: (2023)

Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1
por: Liu, Shuo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dogu3n484v74e731sg6vg1jttq